MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Investment Ideas Pro

Has Abbott Laboratories Just Redefined Its Future with Exact Sciences

2 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Does UBS O'Connor's Big Bet on Exact Sciences Really Mean

1 months ago

Has Alumis's Envudeucitinib Redefined Psoriasis Treatment

1 months ago

Is Kraig Biocraft Laboratories on the Cusp of a Material Revolution

3 weeks ago

What Does Vir Biotechnology's Astellas Deal Mean for Its Future

2 months ago

There's a Revolution in Cancer. But Can Big Pharma Afford It?

Revolution Medicines shares surged following positive developments for its pancreatic-cancer drug candidate. Despite market speculation, a near-term acquisition appears unlikely, suggesting investors ...

RVMD

Stock News•15 hours ago

LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) rose ~235% over the past year, significantly outperforming the 65% gain in the XBI biotech index. This leveraged performance reflects the amplified...

LABU

Stock News•21 hours ago

Will Robust Exome and Genome Revenues Lift GeneDx's Q1 Earnings?

GeneDx enters its Q1 earnings report with strong momentum in exome and genome testing revenues. The company's growth is driven by expanding clinical adoption and a competitive advantage in rare-diseas...

WGS

Stock News•3 days ago

Abbott Laboratories: Buying A Healthcare Giant On Sale

Abbott Laboratories shares fell ~35% to $92.48 as of April 23, 2026, from a March 2025 peak of $141.23. Management issued fiscal 2026 adjusted diluted EPS guidance of $5.38 to $5.58 following the comp...

ABT